FDA Issues Import Ban for Indian Drug Manufacturer
PTSM: Pharmaceutical Technology Sourcing and Management
Polydrug Laboratories is issued a US import alert, following similar bans in Canada and Europe.
FDA has issued an import ban on Sept. 11, 2015 for products manufactured by Polydrug Laboratories at the company’s Ambernath Industrial Area manufacturing plant in Mumbai, India, due to problems with good manufacturing practices for human and animal drugs.
The company manufactures anti-hypertensive, anti-fungal, anti-microbial, and muscle relaxant drugs, and distributes products in Mexico, China, Korea, Russia,Taiwan, Singapore, and Ukraine, according to information posted on the Polydrug Laboratories website.
Reuters reports that Canada and Europe banned products from the same site earlier this year.
Source: FDA Import Alert
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
